The annual 30th BioCity Symposium I 14th Finnish Cancer Institute Symposium with the title CANCER – BREAKING  BAD is arranged on 19-20 August 2021. As you are aware, cancer research is one of Brinter’s core application areas. Hence, we will be on-site at Biocity with our Brinter® 3D bioprinting platform, demonstrating Brinter’s capabilities.

This series of meetings organized since 1991 has become the most important annual get-together in the fields of biosciences and molecular medicine in Turku. The symposium gathers together hundreds of participants each year and offers talks from cutting-edge international researchers.

BioCity Turku is a community of life science and molecular medicine researchers and students in the Turku region. One of its main events is the yearly BioCity Symposium which celebrates its 30th anniversary this year. This year the event is organized in collaboration with Finnish Cancer Institute and the aim is to arrange a hybrid event with some of the audience and invited speakers present in Turku as well as having virtual participants following the broadcasted program.

The Symposium offers an amazing list of invited speakers joining virtually or in person. This year’s program consist of nine talks from international scientists spiced up with short talks from Finnish researchers. One of the speakers is Stephen J. Elledge from Harvard Medical School, who will talk about approaches to immunotherapy for tumors. Other symposium speakers include Leila Akkari from Netherland Cancer Institute researching macrophages in cancer, and Robert A. Gatenby from Moffitt Cancer Center investigating evolutionary dynamics in cancer and cancer drug resistance. Something new this year is a panel discussion with three editors representing different journals from American Association for Cancer Research (AACR). The panel discussion will include short presentations from the journals (Cancer Discovery, Clinical Cancer Research and Cancer Research) and tips and discussion on submitting manuscripts and publishing articles.

Registration to the Symposium is open until Friday the 13th of August.